Astrazeneca ShareCast News (AZN)



ShareCast News for Astrazeneca (AZN)


Share Price: 3,383.00Bid: 3,379.00Ask: 3,379.50Change: 0.00 (0.00%)No Movement on Astrazeneca
Spread: 0.50Spread as %: 0.01%Open: 3,389.00High: 3,396.00Low: 3,369.00Yesterday’s Close: 3,383.00




Friday broker round-up -UPDATE

Fri, 27th Jul 2012 09:54

African Minerals: Goldman Sachs upgrades to buy.

AG Barr: Investec reiterates buy recommendation and 485p target; Shore Capital downgrades to hold; N+1 Brewing downgrades to hold.

AstraZeneca: Nordea downgrades to sell.

Barclays: Investec maintains buy rating and 240p target.

BG Group: UBS cuts target from 1,730p to 1,620p, buy rating unchanged; Jefferies reiterates buy rating and 2,000p target; S&P Equity Research downgrades to hold.

Capita: UBS ups target from 740p to 800p, buy rating kept.

CSR: Jefferies ups target from 290p to 308p, hold rating kept.

FirstGroup: Liberum Capital upgrades to buy.

Intertek: Seymour Pierce downgrades to reduce.

Invensys: Peel Hunt downgrades to hold; Barclays Capital downgrades to equal weight.

Jardine Lloyd Thompson: Investec maintains hold rating and 692p target.

Lamprell: JP Morgan Cazenove downgrades to underweight.

Lonmin: UBS cuts target from 685p to 600p, sell rating kept.

Moneysupermarket.com: UBS ups target from 150p to 160p, buy rating kept.

National Express: Liberum Capital downgrades to hold.

Next: Investec keeps buy rating and 3,500p target.

Spectris: Investec cuts target from 1,900p to 1,715p, buy rating kept; Jefferies reiterates buy rating and 2,020p target.

Pearson: Jefferies keeps hold rating and 1,265p target; Numis downgrades to hold from add.

Reckitt Benckiser: Jefferies keeps hold rating and 3,640p target.

Royal Dutch Shell: Goldman Sachs takes price target down to 2,840p from 2,980p, retains at neutral.

Rolls-Royce: Exane BNP Paribas ups target from 800p to 880p, neutral rating kept.

SABMiller: S&P Equity Research upgrades to hold.

St James's Place: Credit Suisse upgrades to neutral, target lifted from 375p to 400p.

Stagecoach: Liberum Capital upgrades to buy.

Taylor Wimpey: Panmure Gordon upgrades to buy, 53p target kept.

Tullow: UBS cuts target from 1,600p to 1,400p, neutral rating kept. Goldman Sachs lowers price target to 1,776p from 2,020p, neutral rating also kept.

UBM: Investec maintains buy rating and 694p target.

Unilever: Societe Generale downgrades to sell from hold.

United Utilites: Investec ups target from 777p to 791p, buy rating kept.

William Hill: Investec ups target from 330p to 345p, buy rating kept.

BC








Monday broker round-up UPDATE

Afren: Liberum Capital shifts target price from 130p to 136p and maintains a hold recommendation.
[29 Apr '13]

Monday newspaper round-up: BP, AstraZeneca, Sainsbury's...

The Telegraph writes that BP's giant underwater oil project offshore Angola has come in four billion dollars over budget after delays set it back a year.
[29 Apr '13]

Friday tips round-up: Admiral, AstraZeneca

With the motor market under a great deal of regulatory and political scrutiny, The Times' Tempus column has recommended investors to stay clear of Admiral following its 'unimpressive' trading statement on Thursday.
[26 Apr '13]

Friday broker round-up UPDATE

Admiral Group: HB Markets initiates with a buy recommendation.
[26 Apr '13]

London close: Markets underwhelmed by strong growth figures

UK growth figures prompted a mixed reaction on stock markets on Thursday as stronger-than-expected activity in the first quarter quashed hopes that the Bank of England (BoE) would ramp up its quantitative easing programme in order to kick-start the economy.
[25 Apr '13]

FTSE 100 movers: Miners lead the risers

Mining stocks rose on Thursday on the back of rising metal prices, led by Randgold Resources, Antofagasta, Vedanta, ENRC, and Polymetal.
[25 Apr '13]

London midday: Stocks fall as GDP data quashes stimulus hopes

Better-than-expected growth figures from the UK underwhelmed stock markets on Thursday morning, tempering hopes that the Bank of England (BoE) would ease policy to boost the economy.
[25 Apr '13]

Broker tips: Vodafone, AstraZeneca, Admiral

A potential offer by Verizon (VZ) for Vodafone's stake in their US wireless joint venture would have to increase substantially to please the British telecom group's shareholders, according to Jefferies.
[25 Apr '13]




Sign up for Live Prices





Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.